Rhodococcus equi Infection after Alemtuzumab Therapy for T-cell Prolymphocytic Leukemia

Rhodococcus equi, mainly known from veterinary medicine as a pathogen in domestic animals, can also cause infections in immunocompromised humans, especially in those with defects in cellular immunity. Alemtuzumab, an anti-CD52 monoclonal antibody, causes lymphocytopenia by eliminating CD52-positive...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Meeuse, Jan J., Sprenger, Herman G., van Assen, Sander, Leduc, Dominique, Daenen, Simon M.G.J., Arends, Jan P., van der Werf, Tjip S.
Format: Artigo
Langue:Inglês
Publié: Centers for Disease Control and Prevention 2007
Sujets:
Dispatch
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2876741/
https://ncbi.nlm.nih.gov/pubmed/18258054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3201/eid1312.061559
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires